GoBalto joins trial site group; DaVita's CRO launches research contest;

> Clinical trial tech provider goBalto has joined the Society for Clinical Research Sites, a trade group representing more than 2,600 sites. More

> DaVita's in-house CRO launched a program to award use of its biospecimens and patient data to academics pursuing promising projects in kidney disease research. News

> Medidata ($MDSO) has added Chinese drug developer Walvax Biotechnology to its stable of clients. Item